Baxter International Stock News

Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related flooding.

DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an additional two years and expand the agreement to include Canada. Since the signing of the Value-Added Reseller Agreement in June 2023 for the US market, Oneview and Baxter have focused on sales en...

Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at a hurricane-hit plant in North Carolina within the next week.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:15 p.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through ...

Baxter International on Monday said that it aims to restore the number of new patients able to begin using its peritoneal dialysis solutions to pre-Hurricane Helene levels by the end of the year.

Baxter International said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the end of the year to mitigate a shortage caused by Hurricane Helene.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/391655054 to pre-register for the call and receive the call informat...

The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition of Hill-Rom and subsequent challenges, including rising input costs and supply chain issues, have been addressed, setting the stage for recovery. The sale of Baxter's kidney care business and debt r...